a Pathology & Molecular Medicine Seminar!
Localized prostate cancer is one of the most commonly diagnosed tumours, afflicting approximately one in every seven Canadian men. Today, men are stratified into groups with differential risk based on coarse tools like tumor stage, grade and pre-treatment PSA levels. To try to provide improved risk stratification, the Canadian Prostate Cancer Genome Network (CPC-GENE, the largest prostate cancer genomics project in the world) has comprehensively characterized the genomes of over 350 prostate tumours. I will discuss key results from this landscape of prostate cancer that impact our understanding of the etiology, heterogeneity and clinical outcomes of the disease.
Host: Dr. David Berman (email@example.com)
Everyone is welcome!